News Clip2:13
Sky News

Boris Johnson speaking during coronavirus press briefing

Higher Ed
CLEAN: Interior shots of Prime Minister Boris Johnson speaking at a Downing Street Covid-19 press briefing on the first anniversary of the first national lockdown on 23 March 2021 in London, United Kingdom
News Clip5:18
Bloomberg

Johns Hopkins Urges Combining Covid-19 Testing, Contact Tracing

Higher Ed
Jun.19 -- Johns Hopkins Bloomberg School of Public Health Professor Andrew Pekosz discusses what is being learned from Covid-19 testing, contact tracing, and antibody studies. He speaks with Bloomberg’s Francine Lacqua on "Bloomberg...
News Clip6:27
Bloomberg

Hospitals in a ‘Wave Upon a Wave’ of Covid: Johns Hopkins

Higher Ed
Jan.21 -- Johns Hopkins University Professor of Nursing Jason Farley discusses U.S. coronavirus hospitalizations, when the U.S. may see reduced Covid transmission due to vaccinations, and the efficacy of vaccines against Covid variants....
News Clip2:31
Sky News

Patrick Vallance speaking at Downing Street press briefing

Higher Ed
CLEAN: Interior shots of Chief Scientific Officer Patrick Vallance giving a Downing Street press briefing on coronavirus on 22 January 2021 in London, United Kingdom
News Clip1:11
Bloomberg

Fauci Says Mu Covid Variant Isn't Immediate Threat to U.S.

Higher Ed
Sep.03 -- White House chief medical adviser Anthony Fauci says the Mu Covid-19 variant isn't an immediate threat to the U.S.
News Clip4:14
Bloomberg

AstraZeneca Covid Antibody Cocktail Only 33% Effective

Higher Ed
Jun.15 -- AstraZeneca Plc’s antibody cocktail was only 33% effective at preventing symptomatic Covid-19 in people who had been exposed to the virus, failing a study that was key to the drugmaker’s pandemic push. Sam Fazeli of Bloomberg...
News Clip6:12
Bloomberg

Which Vaccine Has the Highest Efficacy Against Delta?

Higher Ed
Jul.19 -- Ben Cowling, professor of infectious disease epidemiology at the University of Hong Kong's School of Public Health who advises the government on the vaccination process, discusses vaccine efficacies. He also talks about his...
News Clip0:29
Curated Video

New Data On Johnson & Johnson Booster Shot

Higher Ed
The data is leading the company to move forward with its booster.
News Clip1:02
Sky News

Dr Michael Jacobs Ebola press conference grab

Higher Ed
Dr Michael Jacobs Ebola press conference grab
News Clip2:39
AFP News Agency

CLEAN : Ebola: Infected British nurse receiving blood plasma treatment

9th - Higher Ed
CLEAN : Ebola: Infected British nurse receiving blood plasma treatment
News Clip1:53
Curated Video

WHO, CDC Say Measles Cases Spiked Globally Last Year

Higher Ed
Health agencies estimate that 140,000 people died from measles last year.
News Clip2:50
Curated Video

2 More Possible Vaccines Get A Fast Track, Raising Wall Street Hopes

Higher Ed
Two more coronavirus vaccine candidates are in a fast lane for FDA approval. But experts say the road to an effective vaccine still has speed bumps.
News Clip7:37
Bloomberg

Loosening Covid-19 Restrictions Shows Mixed Results: Johns Hopkins

Higher Ed
Jun.05 -- Johns Hopkins Bloomberg School of Public Health Professor Andrew Pekosz updates work on vaccines and antibody treatments for Covid-19 and examines the spread of the virus as public restrictions are loosened in the United...
News Clip2:40
Sky News

Matt Hancock speaks at speaks at daily coronavirus press conference

Higher Ed
CLEAN: Interior shots of Downing Street's daily coronavirus press briefing led by Secretary of State for Health and Social Care, Matt Hancock on 5th June 2020 in London, United Kingdom
News Clip2:39
Curated Video

How Cargo-Only Passenger Planes Are Getting Vaccines Beyond U.S.

Higher Ed
United Airlines has been flying vaccines on cargo-only flights for months. Now, as vaccinations slow in the U.S., more doses are headed overseas.
News Clip2:51
Bloomberg

J&J Says Vaccine Shows Strong Protection Against Delta Variant

Higher Ed
Jul.01 -- Johnson & Johnson said that its single-shot coronavirus vaccine neutralizes the fast-spreading delta variant and provides durable protection against infection more broadly. Bloomberg’s Michelle Cortez reports on “Bloomberg...
News Clip5:24
Bloomberg

Omicron Peaking in Weeks, Not Months: Johns Hopkins

Higher Ed
Dr. Amesh Adalja, Johns Hopkins Center for Health Security senior scholar, discusses what has been learned about the omicron variant and suggested guidelines for work and school going forward. The Johns Hopkins Bloomberg School of Public...
News Clip9:05
Bloomberg

China 'Definitely' Needs 2nd Covid Booster Dose: CanSino Biologics CEO

Higher Ed
Yu Xuefeng, chief executive officer of CanSino Biologics Inc., a Tianjin, China-based drugmaker that's rolling out a vaccine that can be inhaled, discusses the supply-demand outlook in the country. He speaks with David Ingles on...
News Clip4:00
Curated Video

Study results suggest 2 Ebola drugs saving lives

Higher Ed
Two Ebola patients who were treated with new drugs in the city of Goma in eastern Congo have been declared "cured" and returned to their home.
News Clip1:18
Curated Video

China's Coronavirus Cases Surge As Researchers Eye New Treatment

Higher Ed
The National Health Commission confirmed 5,000 new cases of the virus in mainland China.
News Clip1:48
Curated Video

Texas Pauses Reopening, ICU Beds Fill As Virus Cases Spike Across U.S.

Higher Ed
As more than half of the country sees new spikes in coronavirus cases, the CDC estimates there may be 10 undocumented cases for each recorded one.
News Clip1:12
Bloomberg

Covid Antibodies Fade Rapidly: Report

Higher Ed
Jul.21 -- Recovering from Covid-19 may not offer much lasting protection from future infections for those with only mild cases. That’s according to a report that suggests caution regarding so-called herd immunity as well as the...
News Clip2:14
Sky News

Q&A at daily press conference on Covid-19 from Downing Street

Higher Ed
CLEAN: Interior shots of Transport Secretary, Grant Shapps and Professor Jonathan Van-Tam answer questions at Downing Street's daily press briefing on Covid-19 on 14th May 2020 in London, United Kingdom
News Clip5:36
Bloomberg

Roche Will Be `Thoughtful' on Regeneron Pricing, CEO Says

Higher Ed
Oct.15 -- Roche Holding AG Chief Executive Officer Severin Schwan discusses the antibody cocktail that the Swiss drugmaker is developing with Regeneron Pharmaceuticals Inc. to treat Covid-19. He speaks from Basel, Switzerland, on...